• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Response to: A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework'.

作者信息

Beck Ekkehard, Bausch-Jurken Mary T, Van de Velde Nicolas, Wang Xuan, Malmenäs Mia

机构信息

Moderna, Inc., 200 Technology Square, Cambridge, MA, 02139, USA.

ICON plc, Stockholm, Sweden.

出版信息

Infect Dis Ther. 2024 Oct;13(10):2195-2202. doi: 10.1007/s40121-024-01020-2. Epub 2024 Aug 24.

DOI:10.1007/s40121-024-01020-2
PMID:39180646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11416437/
Abstract
摘要

相似文献

1
A Response to: A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework'.对一篇致编辑的信的回应：关于“mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析”
Infect Dis Ther. 2024 Oct;13(10):2195-2202. doi: 10.1007/s40121-024-01020-2. Epub 2024 Aug 24.
2
A Letter to the Editor Regarding 'Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework'.致编辑的一封信，关于“mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析”
Infect Dis Ther. 2024 Oct;13(10):2203-2206. doi: 10.1007/s40121-024-01019-9. Epub 2024 Aug 24.
3
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析
Infect Dis Ther. 2024 Apr;13(4):779-811. doi: 10.1007/s40121-024-00936-z. Epub 2024 Mar 18.
4
Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.不同初级疫苗接种方案对基于 mRNA 的 SARS-CoV-2 加强疫苗有效性的比较：利用病毒观察社区队列中的试验模拟进行时变队列分析。
Int J Epidemiol. 2023 Apr 19;52(2):342-354. doi: 10.1093/ije/dyad002.
5
The effectiveness of BNT162b2 mRNA vaccine against COVID-19 caused by Delta variant of SARS-CoV-2: a systematic review and meta-analysis.BNT162b2 mRNA 疫苗对 SARS-CoV-2 德尔塔变异株引起的 COVID-19 的有效性：系统评价和荟萃分析。
Inflammopharmacology. 2022 Feb;30(1):149-157. doi: 10.1007/s10787-021-00915-7. Epub 2022 Jan 31.
6
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
7
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.BNT162b2 BA.4/5 二价 mRNA 疫苗在美国大型医疗体系中针对一系列 COVID-19 结局的有效性：一项病例对照研究。
Lancet Respir Med. 2023 Dec;11(12):1089-1100. doi: 10.1016/S2213-2600(23)00306-5. Epub 2023 Oct 25.
8
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.BNT162b2 与 mRNA-1273 新冠病毒疫苗加强针在英格兰的疗效比较：OpenSAFELY-TPP 的匹配队列研究。
BMJ. 2023 Mar 15;380:e072808. doi: 10.1136/bmj-2022-072808.
9
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines.mRNA-1273、BNT162b2 和 Ad26.COV2.S 新冠病毒疫苗的免疫原性和有效性比较。
J Infect Dis. 2022 Apr 1;225(7):1141-1150. doi: 10.1093/infdis/jiab593.
10
Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant.2019冠状病毒病（COVID-19）疫苗对德尔塔变异株的比较有效性
Clin Infect Dis. 2022 Aug 24;75(1):e623-e629. doi: 10.1093/cid/ciac106.

本文引用的文献

1
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework.mRNA-1273和BNT162b2新冠疫苗在老年人中的比较效果：使用GRADE框架的系统文献综述和荟萃分析
Infect Dis Ther. 2024 Apr;13(4):779-811. doi: 10.1007/s40121-024-00936-z. Epub 2024 Mar 18.
2
Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults.二价（原始毒株/奥密克戎BA.4/BA.5）新冠疫苗在成人中的比较有效性
Vaccines (Basel). 2023 Nov 11;11(11):1711. doi: 10.3390/vaccines11111711.
3
Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022.2022年哥伦比亚加强针预防新冠病毒病的有效性
Vaccines (Basel). 2023 Sep 7;11(9):1461. doi: 10.3390/vaccines11091461.
4
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.四种 COVID-19 疫苗（BNT162b2 mRNA、mRNA-1273、ChAdOx1 nCov-19 和 NVX-CoV2373）对 SARS-CoV-2 B.1.1.529（奥密克戎）感染的有效性比较。
Vaccine. 2023 Aug 31;41(38):5587-5591. doi: 10.1016/j.vaccine.2023.07.050. Epub 2023 Jul 29.
5
Relative Effectiveness of BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines and Homologous Boosting in Preventing COVID-19 in Adults in the US.BNT162b2、mRNA-1273和Ad26.COV2.S疫苗以及同源加强免疫在美国成年人中预防新冠病毒病的相对有效性
Open Forum Infect Dis. 2023 May 25;10(7):ofad288. doi: 10.1093/ofid/ofad288. eCollection 2023 Jul.
6
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses.在北欧国家奥密克戎为主导期间，不同异源第三剂疫苗接种方案对严重 COVID-19 的效果比较：基于人群的队列分析。
BMJ. 2023 Jul 24;382:e074325. doi: 10.1136/bmj-2022-074325.
7
The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies.第一剂 COVID-19 加强针与全剂量疫苗接种预防 SARS-CoV-2 感染和重症 COVID-19 临床事件的效果：纵向研究的荟萃分析和系统评价。
Front Public Health. 2023 Jun 1;11:1165611. doi: 10.3389/fpubh.2023.1165611. eCollection 2023.
8
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021-2022.2021-2022 年比利时接触者追踪的疫苗对阿尔法、德尔塔和奥密克戎 SARS-COV-2 感染传播的有效性。
Vaccine. 2023 May 11;41(20):3292-3300. doi: 10.1016/j.vaccine.2023.03.069. Epub 2023 Apr 5.
9
The effectiveness of COVID-19 vaccines in Latin America, 2021: a multicenter regional case-control study.2021年拉丁美洲新冠疫苗的有效性：一项多中心区域病例对照研究
Lancet Reg Health Am. 2023 Apr;20:100474. doi: 10.1016/j.lana.2023.100474. Epub 2023 Mar 29.
10
Protection from Omicron Infection in Residents of Nursing and Retirement Homes in Ontario, Canada.加拿大安大略省护理院和退休之家居民对奥密克戎感染的防护。
J Am Med Dir Assoc. 2023 May;24(5):753-758. doi: 10.1016/j.jamda.2023.02.105. Epub 2023 Mar 28.